Speaker illustration

Doctor David Newland

Seattle Children's Hospital, Seattle (United States of America)

Member of:

European Society of Cardiology

Dr. David Newland, PharmD, MS, BCPS, BCTXP, is a pharmacotherapy content expert in pediatric cardiology, heart failure, and cardiac transplantation. Dr. Newland has been in clinical practice since 2013. Pertinent research areas include clinical experience using SGLT2i in pediatric heart failure as well as antithrombotic management in pediatric cardiology.

Sodium-glucose cotransporter-2 inhibitor use in children with left ventricular systolic dysfunction: a matched case-control analysis

Event: ESC Congress 2025

Topic: Paediatric Cardiology

Session: Adult congenital heart disease: medical treatment

Thumbnail